Exercise and Treatment-as-usual in Substance Use Treatment Outcomes
NCT ID: NCT02570360
Last Updated: 2019-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2015-09-30
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
exercise
Participants will engage in their outpatient treatment program as-usual, but additionally complete 30mins of moderately intense aerobic exercise 3 times per week for 6 weeks. They will complete 6 weeks of treatment, totaling 18 sessions with exercise.
exercise
The EX participants will engage in supervised, individual treadmill exercise 3xs/wk at the UW Natatorium. Sessions will consist of a 5-minute warm-up followed by 30 minutes of a moderate to moderately-high intensity exercise and then finish with a 5-minute cool down. Questionnaires will be completed before and after exercise on a weekly basis.
treatment-as-usual
Participants will engage in their outpatient treatment program as-usual,but additionally complete 6 weekly, hour-long visits to complete questionnaires. They will complete 6 weeks of treatment (6 sessions total).
treatment-as-usual
The control (standard care) participants will come to the UW-Natatorium on a weekly basis to complete questionnaires.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exercise
The EX participants will engage in supervised, individual treadmill exercise 3xs/wk at the UW Natatorium. Sessions will consist of a 5-minute warm-up followed by 30 minutes of a moderate to moderately-high intensity exercise and then finish with a 5-minute cool down. Questionnaires will be completed before and after exercise on a weekly basis.
treatment-as-usual
The control (standard care) participants will come to the UW-Natatorium on a weekly basis to complete questionnaires.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability to read and write in English sufficient to provide consent and complete study questionnaires
* current diagnosis of a single or of multiple substance use disorders
* currently enrolled in an Intensive Outpatient Treatment substance use program
* desire to quit and to seek treatment for substance use
* currently sedentary, not participating in any formal/structured exercise program
Exclusion Criteria
* presence of cardiac disease or any other medical condition that would make engaging in exercise unsafe
* Undergoing methadone treatment
* chronic conditions such as cancer, diabetes, kidney disease, or autoimmune disorders
* women who are pregnant or planning to become pregnant
21 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Medical College of Wisconsin
OTHER
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Angelique Brellenthin, MS
Role: PRINCIPAL_INVESTIGATOR
UW-Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Wisconsin-Madison
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Brellenthin AG, Crombie KM, Hillard CJ, Brown RT, Koltyn KF. Psychological and endocannabinoid responses to aerobic exercise in substance use disorder patients. Subst Abus. 2021;42(3):272-283. doi: 10.1080/08897077.2019.1680480. Epub 2019 Nov 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A176000
Identifier Type: OTHER
Identifier Source: secondary_id
EDUC\KINESIOLOGY\KINESIO
Identifier Type: OTHER
Identifier Source: secondary_id
2015-0710
Identifier Type: -
Identifier Source: org_study_id